Waters Corporation  

(Public, NYSE:WAT)   Watch this stock  
Find more results for DEF Corporation(s)
120.62
+1.67 (1.40%)
Jan 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 117.84 - 120.72
52 week 93.56 - 122.80
Open 118.80
Vol / Avg. 466,959.00/442,164.00
Mkt cap 9.92B
P/E 23.66
Div/yield     -
EPS 5.10
Shares 83.24M
Beta 0.94
Inst. own 90%
Apr 27, 2015
Q1 2015 Waters Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 26, 2015
Q4 2014 Waters Corp Earnings Call - Webcast
Jan 26, 2015
Q4 2014 Waters Corp Earnings Release
Jan 12, 2015
Waters Corp at JPMorgan Healthcare Conference
Nov 18, 2014
Waters Corporation at Stifel Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 25.91% 21.70%
Operating margin 29.47% 26.03%
EBITD margin - 27.46%
Return on average assets 15.91% 11.57%
Return on average equity 32.48% 23.60%
Employees 6,000 -
CDP Score - 75 C

Address

34 MAPLE ST
MILFORD, MA 01757
United States - Map
+1-508-4782000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Waters Corporation is an analytical instrument manufacturer that primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. The Company operates in two segments: Waters Division and TA Division. Through its TA Division (TA), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications.

Officers and directors

Douglas A. Berthiaume Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Eugene G. Cassis Interim Chief Financial Officer, Corporate Vice President - Worldwide Business Development and Investor Relations
Age: 57
Bio & Compensation  - Reuters
Arthur G. Caputo Executive Vice President, President - Waters Division
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark T. Beaudouin Vice President, General Counsel, Secretary
Age: 59
Bio & Compensation  - Reuters
Elizabeth B. Rae Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Thomas P. Salice Lead Independent Director
Age: 54
Bio & Compensation  - Reuters
Joshua Bekenstein Independent Director
Age: 55
Bio & Compensation  - Reuters
Michael Joseph Berendt Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters
Edward W. Conard Independent Director
Age: 57
Bio & Compensation  - Reuters
Laurie H. Glimcher M.D. Independent Director
Age: 62
Bio & Compensation  - Reuters